Health-related quality of life in long-term survivors of relapsed childhood acute lymphoblastic leukemia

Relapses occur in about 20% of children with acute lymphoblastic leukemia (ALL). Approximately one-third of these children can be cured. Their risk for late effects is high because of intensified treatment, but their health-related quality of life (HRQOL) was largely unmeasured. Our aim was to compa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2012-05, Vol.7 (5), p.e38015-e38015
Hauptverfasser: Essig, Stefan, von der Weid, Nicolas X, Strippoli, Marie-Pierre F, Rebholz, Cornelia E, Michel, Gisela, Rueegg, Corina S, Niggli, Felix K, Kuehni, Claudia E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e38015
container_issue 5
container_start_page e38015
container_title PloS one
container_volume 7
creator Essig, Stefan
von der Weid, Nicolas X
Strippoli, Marie-Pierre F
Rebholz, Cornelia E
Michel, Gisela
Rueegg, Corina S
Niggli, Felix K
Kuehni, Claudia E
description Relapses occur in about 20% of children with acute lymphoblastic leukemia (ALL). Approximately one-third of these children can be cured. Their risk for late effects is high because of intensified treatment, but their health-related quality of life (HRQOL) was largely unmeasured. Our aim was to compare HRQOL of ALL survivors with the general population, and of relapsed with non-relapsed ALL survivors. As part of the Swiss Childhood Cancer Survivor Study (SCCSS) we sent a questionnaire to all ALL survivors in Switzerland who had been diagnosed between 1976-2003 at age
doi_str_mv 10.1371/journal.pone.0038015
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1325022139</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A477041751</galeid><doaj_id>oai_doaj_org_article_17a27f2e3977434d85a86074d6c30f12</doaj_id><sourcerecordid>A477041751</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-5427f9f6fe760ea652052a50be394877ff30f2fdfe8c1077113af1d7ceace49d3</originalsourceid><addsrcrecordid>eNqNk11r2zAUhs3YWLtu_2BshsHYLpzpw5bsm0Ip2xooFPZ1KxT5KFamWKkkh-XfT2ncEo9eDGNspOd9z4d0suw1RjNMOf60coPvpZ1tXA8zhGiNcPUkO8UNJQUjiD49-j_JXoSwQqiiNWPPsxNCGEsvOc26K5A2doUHKyO0-e0grYm73OncGg256XPr-mURwa_zMPit2Tof9tt7xSYkieqMbTvn2lyqIUJud-tN5xZWhmhUbmH4DWsjX2bPtLQBXo3fs-znl88_Lq-K65uv88uL60KxhsSiKgnXjWYaOEMgWUVQRWSFFkCbsuZca4o00a2GWmHEOcZUatxyBVJB2bT0LHt78N1YF8TYpCAwJRUiBNMmEfMD0Tq5Ehtv1tLvhJNG3C04vxTSp9QtCMxlSoek2JyXtGzrStYM8bJlKqWBSfI6H6MNizW0CvropZ2YTnd604ml2wpKGWIlSgYfRgPvbgcIUaxNUGCt7MENKW9EakRSpTSh7_5BH69upJYyFWB67VJctTcVFyXnqMS8womaPUKlp01npdKN0iatTwQfJ4LERPgTl3IIQcy_f_t_9ubXlH1_xHZ3lzE4O0Tj-jAFywOovAvBg35oMkZiPxD33RD7gRDjQCTZm-MDehDdTwD9Cy7qBec</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1325022139</pqid></control><display><type>article</type><title>Health-related quality of life in long-term survivors of relapsed childhood acute lymphoblastic leukemia</title><source>Public Library of Science (PLoS) Journals Open Access</source><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Essig, Stefan ; von der Weid, Nicolas X ; Strippoli, Marie-Pierre F ; Rebholz, Cornelia E ; Michel, Gisela ; Rueegg, Corina S ; Niggli, Felix K ; Kuehni, Claudia E</creator><creatorcontrib>Essig, Stefan ; von der Weid, Nicolas X ; Strippoli, Marie-Pierre F ; Rebholz, Cornelia E ; Michel, Gisela ; Rueegg, Corina S ; Niggli, Felix K ; Kuehni, Claudia E ; Swiss Pediatric Oncology Group (SPOG) ; for the Swiss Pediatric Oncology Group (SPOG)</creatorcontrib><description>Relapses occur in about 20% of children with acute lymphoblastic leukemia (ALL). Approximately one-third of these children can be cured. Their risk for late effects is high because of intensified treatment, but their health-related quality of life (HRQOL) was largely unmeasured. Our aim was to compare HRQOL of ALL survivors with the general population, and of relapsed with non-relapsed ALL survivors. As part of the Swiss Childhood Cancer Survivor Study (SCCSS) we sent a questionnaire to all ALL survivors in Switzerland who had been diagnosed between 1976-2003 at age &lt;16 years, survived ≥5 years, and were currently aged ≥16 years. HRQOL was assessed with the Short Form-36 (SF-36), which measures four aspects of physical health and four aspects of mental health. A score of 50 corresponded to the mean of a healthy reference population. We analyzed data from 457 ALL survivors (response: 79%). Sixty-one survivors had suffered a relapse. Compared to the general population, ALL survivors reported similar or higher HRQOL scores on all scales. Survivors with a relapse scored lower in general health perceptions (51.6) compared to those without (55.8;p=0.005), but after adjusting for self-reported late effects, this difference disappeared. Compared to population norms, ALL survivors reported good HRQOL, even after a relapse. However, relapsed ALL survivors reported poorer general health than non-relapsed. Therefore, we encourage specialists to screen for poor general health in survivors after a relapse and, when appropriate, specifically seek and treat underlying late effects. This will help to improve patients' HRQOL.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0038015</identifier><identifier>PMID: 22662262</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Acute lymphatic leukemia ; Acute lymphoblastic leukemia ; Acute lymphocytic leukemia ; Adolescent ; Analysis ; Cancer ; Cancer therapies ; Child ; Child, Preschool ; Childhood ; Children ; Data processing ; Ethics ; Female ; Health ; Health risk assessment ; Health screening ; Humans ; Infant ; Infant, Newborn ; Leukemia ; Lymphatic leukemia ; Male ; Medical diagnosis ; Medicine ; Mental health ; Nervous system ; Norms ; Oncology ; Pediatrics ; Population ; Precursor Cell Lymphoblastic Leukemia-Lymphoma - psychology ; Preventive medicine ; Quality of Life ; Quantitative psychology ; Questionnaires ; Recurrence ; Recurrence (Disease) ; Stem cell transplantation ; Studies ; Surveys ; Surveys and Questionnaires ; Survivors - psychology ; Switzerland ; Tumors</subject><ispartof>PloS one, 2012-05, Vol.7 (5), p.e38015-e38015</ispartof><rights>COPYRIGHT 2012 Public Library of Science</rights><rights>2012 Essig et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Essig et al. 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-5427f9f6fe760ea652052a50be394877ff30f2fdfe8c1077113af1d7ceace49d3</citedby><cites>FETCH-LOGICAL-c692t-5427f9f6fe760ea652052a50be394877ff30f2fdfe8c1077113af1d7ceace49d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360640/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360640/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79342,79343</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22662262$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Essig, Stefan</creatorcontrib><creatorcontrib>von der Weid, Nicolas X</creatorcontrib><creatorcontrib>Strippoli, Marie-Pierre F</creatorcontrib><creatorcontrib>Rebholz, Cornelia E</creatorcontrib><creatorcontrib>Michel, Gisela</creatorcontrib><creatorcontrib>Rueegg, Corina S</creatorcontrib><creatorcontrib>Niggli, Felix K</creatorcontrib><creatorcontrib>Kuehni, Claudia E</creatorcontrib><creatorcontrib>Swiss Pediatric Oncology Group (SPOG)</creatorcontrib><creatorcontrib>for the Swiss Pediatric Oncology Group (SPOG)</creatorcontrib><title>Health-related quality of life in long-term survivors of relapsed childhood acute lymphoblastic leukemia</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Relapses occur in about 20% of children with acute lymphoblastic leukemia (ALL). Approximately one-third of these children can be cured. Their risk for late effects is high because of intensified treatment, but their health-related quality of life (HRQOL) was largely unmeasured. Our aim was to compare HRQOL of ALL survivors with the general population, and of relapsed with non-relapsed ALL survivors. As part of the Swiss Childhood Cancer Survivor Study (SCCSS) we sent a questionnaire to all ALL survivors in Switzerland who had been diagnosed between 1976-2003 at age &lt;16 years, survived ≥5 years, and were currently aged ≥16 years. HRQOL was assessed with the Short Form-36 (SF-36), which measures four aspects of physical health and four aspects of mental health. A score of 50 corresponded to the mean of a healthy reference population. We analyzed data from 457 ALL survivors (response: 79%). Sixty-one survivors had suffered a relapse. Compared to the general population, ALL survivors reported similar or higher HRQOL scores on all scales. Survivors with a relapse scored lower in general health perceptions (51.6) compared to those without (55.8;p=0.005), but after adjusting for self-reported late effects, this difference disappeared. Compared to population norms, ALL survivors reported good HRQOL, even after a relapse. However, relapsed ALL survivors reported poorer general health than non-relapsed. Therefore, we encourage specialists to screen for poor general health in survivors after a relapse and, when appropriate, specifically seek and treat underlying late effects. This will help to improve patients' HRQOL.</description><subject>Acute lymphatic leukemia</subject><subject>Acute lymphoblastic leukemia</subject><subject>Acute lymphocytic leukemia</subject><subject>Adolescent</subject><subject>Analysis</subject><subject>Cancer</subject><subject>Cancer therapies</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Childhood</subject><subject>Children</subject><subject>Data processing</subject><subject>Ethics</subject><subject>Female</subject><subject>Health</subject><subject>Health risk assessment</subject><subject>Health screening</subject><subject>Humans</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Leukemia</subject><subject>Lymphatic leukemia</subject><subject>Male</subject><subject>Medical diagnosis</subject><subject>Medicine</subject><subject>Mental health</subject><subject>Nervous system</subject><subject>Norms</subject><subject>Oncology</subject><subject>Pediatrics</subject><subject>Population</subject><subject>Precursor Cell Lymphoblastic Leukemia-Lymphoma - psychology</subject><subject>Preventive medicine</subject><subject>Quality of Life</subject><subject>Quantitative psychology</subject><subject>Questionnaires</subject><subject>Recurrence</subject><subject>Recurrence (Disease)</subject><subject>Stem cell transplantation</subject><subject>Studies</subject><subject>Surveys</subject><subject>Surveys and Questionnaires</subject><subject>Survivors - psychology</subject><subject>Switzerland</subject><subject>Tumors</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNqNk11r2zAUhs3YWLtu_2BshsHYLpzpw5bsm0Ip2xooFPZ1KxT5KFamWKkkh-XfT2ncEo9eDGNspOd9z4d0suw1RjNMOf60coPvpZ1tXA8zhGiNcPUkO8UNJQUjiD49-j_JXoSwQqiiNWPPsxNCGEsvOc26K5A2doUHKyO0-e0grYm73OncGg256XPr-mURwa_zMPit2Tof9tt7xSYkieqMbTvn2lyqIUJud-tN5xZWhmhUbmH4DWsjX2bPtLQBXo3fs-znl88_Lq-K65uv88uL60KxhsSiKgnXjWYaOEMgWUVQRWSFFkCbsuZca4o00a2GWmHEOcZUatxyBVJB2bT0LHt78N1YF8TYpCAwJRUiBNMmEfMD0Tq5Ehtv1tLvhJNG3C04vxTSp9QtCMxlSoek2JyXtGzrStYM8bJlKqWBSfI6H6MNizW0CvropZ2YTnd604ml2wpKGWIlSgYfRgPvbgcIUaxNUGCt7MENKW9EakRSpTSh7_5BH69upJYyFWB67VJctTcVFyXnqMS8womaPUKlp01npdKN0iatTwQfJ4LERPgTl3IIQcy_f_t_9ubXlH1_xHZ3lzE4O0Tj-jAFywOovAvBg35oMkZiPxD33RD7gRDjQCTZm-MDehDdTwD9Cy7qBec</recordid><startdate>20120525</startdate><enddate>20120525</enddate><creator>Essig, Stefan</creator><creator>von der Weid, Nicolas X</creator><creator>Strippoli, Marie-Pierre F</creator><creator>Rebholz, Cornelia E</creator><creator>Michel, Gisela</creator><creator>Rueegg, Corina S</creator><creator>Niggli, Felix K</creator><creator>Kuehni, Claudia E</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20120525</creationdate><title>Health-related quality of life in long-term survivors of relapsed childhood acute lymphoblastic leukemia</title><author>Essig, Stefan ; von der Weid, Nicolas X ; Strippoli, Marie-Pierre F ; Rebholz, Cornelia E ; Michel, Gisela ; Rueegg, Corina S ; Niggli, Felix K ; Kuehni, Claudia E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-5427f9f6fe760ea652052a50be394877ff30f2fdfe8c1077113af1d7ceace49d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Acute lymphatic leukemia</topic><topic>Acute lymphoblastic leukemia</topic><topic>Acute lymphocytic leukemia</topic><topic>Adolescent</topic><topic>Analysis</topic><topic>Cancer</topic><topic>Cancer therapies</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Childhood</topic><topic>Children</topic><topic>Data processing</topic><topic>Ethics</topic><topic>Female</topic><topic>Health</topic><topic>Health risk assessment</topic><topic>Health screening</topic><topic>Humans</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Leukemia</topic><topic>Lymphatic leukemia</topic><topic>Male</topic><topic>Medical diagnosis</topic><topic>Medicine</topic><topic>Mental health</topic><topic>Nervous system</topic><topic>Norms</topic><topic>Oncology</topic><topic>Pediatrics</topic><topic>Population</topic><topic>Precursor Cell Lymphoblastic Leukemia-Lymphoma - psychology</topic><topic>Preventive medicine</topic><topic>Quality of Life</topic><topic>Quantitative psychology</topic><topic>Questionnaires</topic><topic>Recurrence</topic><topic>Recurrence (Disease)</topic><topic>Stem cell transplantation</topic><topic>Studies</topic><topic>Surveys</topic><topic>Surveys and Questionnaires</topic><topic>Survivors - psychology</topic><topic>Switzerland</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Essig, Stefan</creatorcontrib><creatorcontrib>von der Weid, Nicolas X</creatorcontrib><creatorcontrib>Strippoli, Marie-Pierre F</creatorcontrib><creatorcontrib>Rebholz, Cornelia E</creatorcontrib><creatorcontrib>Michel, Gisela</creatorcontrib><creatorcontrib>Rueegg, Corina S</creatorcontrib><creatorcontrib>Niggli, Felix K</creatorcontrib><creatorcontrib>Kuehni, Claudia E</creatorcontrib><creatorcontrib>Swiss Pediatric Oncology Group (SPOG)</creatorcontrib><creatorcontrib>for the Swiss Pediatric Oncology Group (SPOG)</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Essig, Stefan</au><au>von der Weid, Nicolas X</au><au>Strippoli, Marie-Pierre F</au><au>Rebholz, Cornelia E</au><au>Michel, Gisela</au><au>Rueegg, Corina S</au><au>Niggli, Felix K</au><au>Kuehni, Claudia E</au><aucorp>Swiss Pediatric Oncology Group (SPOG)</aucorp><aucorp>for the Swiss Pediatric Oncology Group (SPOG)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Health-related quality of life in long-term survivors of relapsed childhood acute lymphoblastic leukemia</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2012-05-25</date><risdate>2012</risdate><volume>7</volume><issue>5</issue><spage>e38015</spage><epage>e38015</epage><pages>e38015-e38015</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Relapses occur in about 20% of children with acute lymphoblastic leukemia (ALL). Approximately one-third of these children can be cured. Their risk for late effects is high because of intensified treatment, but their health-related quality of life (HRQOL) was largely unmeasured. Our aim was to compare HRQOL of ALL survivors with the general population, and of relapsed with non-relapsed ALL survivors. As part of the Swiss Childhood Cancer Survivor Study (SCCSS) we sent a questionnaire to all ALL survivors in Switzerland who had been diagnosed between 1976-2003 at age &lt;16 years, survived ≥5 years, and were currently aged ≥16 years. HRQOL was assessed with the Short Form-36 (SF-36), which measures four aspects of physical health and four aspects of mental health. A score of 50 corresponded to the mean of a healthy reference population. We analyzed data from 457 ALL survivors (response: 79%). Sixty-one survivors had suffered a relapse. Compared to the general population, ALL survivors reported similar or higher HRQOL scores on all scales. Survivors with a relapse scored lower in general health perceptions (51.6) compared to those without (55.8;p=0.005), but after adjusting for self-reported late effects, this difference disappeared. Compared to population norms, ALL survivors reported good HRQOL, even after a relapse. However, relapsed ALL survivors reported poorer general health than non-relapsed. Therefore, we encourage specialists to screen for poor general health in survivors after a relapse and, when appropriate, specifically seek and treat underlying late effects. This will help to improve patients' HRQOL.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>22662262</pmid><doi>10.1371/journal.pone.0038015</doi><tpages>e38015</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2012-05, Vol.7 (5), p.e38015-e38015
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_1325022139
source Public Library of Science (PLoS) Journals Open Access; MEDLINE; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry
subjects Acute lymphatic leukemia
Acute lymphoblastic leukemia
Acute lymphocytic leukemia
Adolescent
Analysis
Cancer
Cancer therapies
Child
Child, Preschool
Childhood
Children
Data processing
Ethics
Female
Health
Health risk assessment
Health screening
Humans
Infant
Infant, Newborn
Leukemia
Lymphatic leukemia
Male
Medical diagnosis
Medicine
Mental health
Nervous system
Norms
Oncology
Pediatrics
Population
Precursor Cell Lymphoblastic Leukemia-Lymphoma - psychology
Preventive medicine
Quality of Life
Quantitative psychology
Questionnaires
Recurrence
Recurrence (Disease)
Stem cell transplantation
Studies
Surveys
Surveys and Questionnaires
Survivors - psychology
Switzerland
Tumors
title Health-related quality of life in long-term survivors of relapsed childhood acute lymphoblastic leukemia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T13%3A28%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Health-related%20quality%20of%20life%20in%20long-term%20survivors%20of%20relapsed%20childhood%20acute%20lymphoblastic%20leukemia&rft.jtitle=PloS%20one&rft.au=Essig,%20Stefan&rft.aucorp=Swiss%20Pediatric%20Oncology%20Group%20(SPOG)&rft.date=2012-05-25&rft.volume=7&rft.issue=5&rft.spage=e38015&rft.epage=e38015&rft.pages=e38015-e38015&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0038015&rft_dat=%3Cgale_plos_%3EA477041751%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1325022139&rft_id=info:pmid/22662262&rft_galeid=A477041751&rft_doaj_id=oai_doaj_org_article_17a27f2e3977434d85a86074d6c30f12&rfr_iscdi=true